Indication
Fasciitis, Eosinophilic
1 clinical trial
1 product
Clinical trial
Mepolizumab for the Treatment of Eosinophilic Fasciitis; An Open-Label, Single-Arm, Exploration StudyStatus: Withdrawn, Estimated PCD: 2025-12-01
Product
Mepolizumab1 clinical trial
1 product